{
  "variants": [
    {
      "gene": "LRRK2",
      "protein_change": "G2019S",
      "variant_string_id": "LRRK2 G2019S",
      "assessment": {
        "step_1": {
          "extracted_paper_info": "The study links LRRK2 mutations to PD through kinase activity, as LRRK2's role in Parkinson's is tied to its kinase function.",
          "decision": "Yes"
        },
        "step_2": {
          "extracted_paper_info": "The KESTREL screen measures kinase activity, directly relevant to the disease mechanism of LRRK2 mutations.",
          "decision": "Yes"
        },
        "step_3": {
          "sub_step_3a": {
            "extracted_paper_info": "The study tested nine mutations, including wild-type and pathogenic/benign controls, with multiple replicates.",
            "decision": "Yes"
          },
          "sub_step_3b": {
            "extracted_paper_info": "The assay was validated through multiple mutant comparisons, with no mention of novel assay conditions.",
            "decision": "Yes"
          },
          "sub_step_3c": {
            "extracted_paper_info": "The study compared variants against each other (e.g., G2019S vs. R1941H) as controls.",
            "decision": "Yes"
          }
        },
        "step_4": {
          "sub_step_4a": {
            "extracted_paper_info": "The paper reports that only G2019S stimulated kinase activity, while others inhibited or had no effect.",
            "decision": "Yes"
          },
          "sub_step_4b": {
            "extracted_paper_info": "The study included 9 variants, with 1 (G2019S) as a positive control and 4 (R1941H, I2012T, I2020T, G2385R) as negative controls.",
            "decision": "Yes"
          },
          "sub_step_4c": {
            "extracted_paper_info": "G2019S showed a clear stimulatory effect, while others showed inhibitory or neutral results, indicating strong functional evidence.",
            "decision": "PS3_very_strong"
          }
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "R1941H",
      "variant_string_id": "LRRK2 R1941H",
      "assessment": {
        "step_1": {
          "extracted_paper_info": "The disease mechanism is tied to LRRK2's kinase activity, as mutations affecting this function are linked to PD.",
          "decision": "Yes"
        },
        "step_2": {
          "extracted_paper_info": "The KESTREL screen measures kinase activity, directly relevant to the disease mechanism.",
          "decision": "Yes"
        },
        "step_3": {
          "sub_step_3a": {
            "extracted_paper_info": "The study tested nine mutations, including wild-type and pathogenic/benign controls, with multiple replicates.",
            "decision": "Yes"
          },
          "sub_step_3b": {
            "extracted_paper_info": "The assay was validated through multiple mutant comparisons, with no mention of novel assay conditions.",
            "decision": "Yes"
          },
          "sub_step_3c": {
            "extracted_paper_info": "The study compared variants against each other (e.g., G2019S vs. R1941H) as controls.",
            "decision": "Yes"
          }
        },
        "step_4": {
          "sub_step_4a": {
            "extracted_paper_info": "The paper reports that R1941H inhibited kinase activity, with other variants showing similar results.",
            "decision": "Yes"
          },
          "sub_step_4b": {
            "extracted_paper_info": "The study included 9 variants, with 1 (G2019S) as a positive control and 4 (R1941H, I2012T, I2020T, G2385R) as negative controls.",
            "decision": "Yes"
          },
          "sub_step_4c": {
            "extracted_paper_info": "R1941H showed a clear inhibitory effect, indicating strong functional evidence.",
            "decision": "PS3_supporting"
          }
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "I2012T",
      "variant_string_id": "LRRK2 I2012T",
      "assessment": {
        "step_1": {
          "extracted_paper_info": "The disease mechanism is tied to LRRK2's kinase activity, as mutations affecting this function are linked to PD.",
          "decision": "Yes"
        },
        "step_2": {
          "extracted_paper_info": "The KESTREL screen measures kinase activity, directly relevant to the disease mechanism.",
          "decision": "Yes"
        },
        "step_3": {
          "sub_step_3a": {
            "extracted_paper_info": "The study tested nine mutations, including wild-type and pathogenic/benign controls, with multiple replicates.",
            "decision": "Yes"
          },
          "sub_step_3b": {
            "extracted_paper_info": "The assay was validated through multiple mutant comparisons, with no mention of novel assay conditions.",
            "decision": "Yes"
          },
          "sub_step_3c": {
            "extracted_paper_info": "The study compared variants against each other (e.g., G2019S vs. I2012T) as controls.",
            "decision": "Yes"
          }
        },
        "step_4": {
          "sub_step_4a": {
            "extracted_paper_info": "The paper reports that I2012T inhibited kinase activity, with other variants showing similar results.",
            "decision": "Yes"
          },
          "sub_step_4b": {
            "extracted_paper_info": "The study included 9 variants, with 1 (G2019S) as a positive control and 4 (R1941H, I2012T, I2020T, G2385R) as negative controls.",
            "decision": "Yes"
          },
          "sub_step_4c": {
            "extracted_paper_info": "I2012T showed a clear inhibitory effect, indicating strong functional evidence.",
            "decision": "PS3_supporting"
          }
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "I2020T",
      "variant_string_id": "LRRK2 I2020T",
      "assessment": {
        "step_1": {
          "extracted_paper_info": "The disease mechanism is tied to LRRK2's kinase activity, as mutations affecting this function are linked to PD.",
          "decision": "Yes"
        },
        "step_2": {
          "extracted_paper_info": "The KESTREL screen measures kinase activity, directly relevant to the disease mechanism.",
          "decision": "Yes"
        },
        "step_3": {
          "sub_step_3a": {
            "extracted_paper_info": "The study tested nine mutations, including wild-type and pathogenic/benign controls, with multiple replicates.",
            "decision": "Yes"
          },
          "sub_step_3b": {
            "extracted_paper_info": "The assay was validated through multiple mutant comparisons, with no mention of novel assay conditions.",
            "decision": "Yes"
          },
          "sub_step_3c": {
            "extracted_paper_info": "The study compared variants against each other (e.g., G2019S vs. I2020T) as controls.",
            "decision": "Yes"
          }
        },
        "step_4": {
          "sub_step_4a": {
            "extracted_paper_info": "The paper reports that I2020T inhibited kinase activity, with other variants showing similar results.",
            "decision": "Yes"
          },
          "sub_step_4b": {
            "extracted_paper_info": "The study included 9 variants, with 1 (G2019S) as a positive control and 4 (R1941H, I2012T, I2020T, G2385R) as negative controls.",
            "decision": "Yes"
          },
          "sub_step_4c": {
            "extracted_paper_info": "I2020T showed a clear inhibitory effect, indicating strong functional evidence.",
            "decision": "PS3_supporting"
          }
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "G2385R",
      "variant_string_id": "LRRK2 G2385R",
      "assessment": {
        "step_1": {
          "extracted_paper_info": "The disease mechanism is tied to LRRK2's kinase activity, as mutations affecting this function are linked to PD.",
          "decision": "Yes"
        },
        "step_2": {
          "extracted_paper_info": "The KESTREL screen measures kinase activity, directly relevant to the disease mechanism.",
          "decision": "Yes"
        },
        "step_3": {
          "sub_step_3a": {
            "extracted_paper_info": "The study tested nine mutations, including wild-type and pathogenic/benign controls, with multiple replicates.",
            "decision": "Yes"
          },
          "sub_step_3b": {
            "extracted_paper_info": "The assay was validated through multiple mutant comparisons, with no mention of novel assay conditions.",
            "decision": "Yes"
          },
          "sub_step_3c": {
            "extracted_paper_info": "The study compared variants against each other (e.g., G2019S vs. G2385R) as controls.",
            "decision": "Yes"
          }
        },
        "step_4": {
          "sub_step_4a": {
            "extracted_paper_info": "The paper reports that G2385R inhibited kinase activity, with other variants showing similar results.",
            "decision": "Yes"
          },
          "sub_step_4b": {
            "extracted_paper_info": "The study included 9 variants, with 1 (G2019S) as a positive control and 4 (R1941H, I2012T, I2020T, G2385R) as negative controls.",
            "decision": "Yes"
          },
          "sub_step_4c": {
            "extracted_paper_info": "G2385R showed a clear inhibitory effect, indicating strong functional evidence.",
            "decision": "PS3_supporting"
          }
        }
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": "R1941H",
      "variant_string_id": "LRRK2 R1941H",
      "assessment": {
        "step_1": {
          "extracted_paper_info": "The disease mechanism is tied to LRRK2's kinase activity, as mutations affecting this function are linked to PD.",
          "decision": "Yes"
        },
        "step_2": {
          "extracted_paper_info": "The KESTREL screen measures kinase activity, directly relevant to the disease mechanism.",
          "decision": "Yes"
        },
        "step_3": {
          "sub_step_3a": {
            "extracted_paper_info": "The study tested nine mutations, including wild-type and pathogenic/benign controls, with multiple replicates.",
            "decision": "Yes"
          },
          "sub_step_3b": {
            "extracted_paper_info": "The assay was validated through multiple mutant comparisons, with no mention of novel assay conditions.",
            "decision": "Yes"
          },
          "sub_step_3c": {
            "extracted_paper_info": "The study compared variants against each other (e.g., G2019S vs. R1941H) as controls.",
            "decision": "Yes"
          }
        },
        "step_4": {
          "sub_step_4a": {
            "extracted_paper_info": "The paper reports that R1941H inhibited kinase activity, with other variants showing similar results.",
            "decision": "Yes"
          },
          "sub_step_4b": {
            "extracted_paper_info": "The study included 9 variants, with 1 (G2019S) as a positive control and 4 (R1941H, I2012T, I2020T, G2385R) as negative controls.",
            "decision": "Yes"
          },
          "sub_step_4c": {
            "extracted_paper_info": "R1941H showed a clear inhibitory effect, indicating strong functional evidence.",
            "decision": "PS3_supporting"
          }
        }
      }
    }
  ]
}